Kailera Therapeutics reported earnings of -$ 0.74 per KLRA share on Nov 4, 2026, beating analysts' expectations by
| Report Date | Nov 4, 2026 |
|---|---|
| Forecasted EPS | -$ 0.73 |
| Earnings Per Share (Surprise) | -$ 0.74 (-$ 0.01) |
Out of the last 4 earnings reporting periods, Kailera Therapeutics beat analysts’ expectations 1 times and fell short of expectations 3 time(s). Kailera Therapeutics reported earnings per share of -$ 0.74 in the last report falling to reach an estimated EPS of -$ 0.73 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 4, 2026 | -$ 0.73 | -$ 0.74 | - | - |
| Aug 25, 2026 | -$ 0.74 | - | - | |
| Aug 12, 2026 | -$ 0.90 | -$ 1.09 | - | - |
| May 26, 2026 | -$ 0.78 | -$ 3,650.00 | - | - |
Kailera Therapeutics’s stock was trading at $ 12.58 on Nov 3, 2026 a day before the last earnings report was released.Following the release of the earnings report, KLRA’s price decreased to $ 12.17 on Nov 5, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 4, 2026 | -$ 0.74 | $ 12.58 | $ 12.17 | |
| Aug 25, 2026 | | $ 16.54 | $ 18.44 | |
| Aug 12, 2026 | -$ 1.09 | $ 18.87 | $ 17.97 | |
| May 26, 2026 | -$ 3,650.00 | $ 21.17 | $ 21.91 |
Kailera Therapeutics released its most recent earnings reports in November 2026, August 2026, August 2026, May 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Kailera Therapeutics missed analysts’ expectations during the last earnings period by
